| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222085 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
Low-dose-rate prostate brachytherapy is very well tolerated and rectal bleeding toxicities are either self-resolving or effectively managed by medical intervention. Treatment planning incorporating adjuvant ADT while minimizing RV100 has yielded the best toxicity-free survival following BT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeremy G. BA, Nelson N. MD, Richard G. MD,